Use of a formalin-treated, live Escherichia coli vaccine in the prevention of neonatal enteric colibacillosis in swine [Bacterial diseases]

A field trial was conducted to evaluate the effectiveness of an Escherichia coli vaccine in prevention of neonatal enteric colibacillosis in swine. Sows (272 total) were allotted to control (151 sows) and vaccinated groups (121 sows). Sows in the vaccinated groups were given a single intramuscular i...

Full description

Saved in:
Bibliographic Details
Published inJournal of the American Veterinary Medical Association Vol. 168; no. 4; p. 317
Main Authors Ward, G E, Bigland, C H
Format Journal Article
LanguageEnglish
Published United States 01.01.1976
Subjects
Animals
Animals, Newborn
Bacterial Vaccines
Diarrhea - prevention & control
Diarrhea - veterinary
Escherichia coli Infections - prevention & control
Escherichia coli Infections - veterinary
Formaldehyde - pharmacology
Swine
Swine Diseases - prevention & control
Online AccessGet more information

Cover

More Information
Summary:A field trial was conducted to evaluate the effectiveness of an Escherichia coli vaccine in prevention of neonatal enteric colibacillosis in swine. Sows (272 total) were allotted to control (151 sows) and vaccinated groups (121 sows). Sows in the vaccinated groups were given a single intramuscular injection of a formalin-treated, live E coli vaccine 10 to 20 days prior to farrowing. The effects of the vaccination were to: (1) reduce mortality from 2.14 to 0.93 (P less than 0.001) pigs per litter; (2) reduce number of pigs with diarrhea, from 7.28 to 3.12 (P less than 0.004) per litter; and (3) increase number of pigs weaned, from 7.62 to 8.2 (P less than 0.005) per litter. The advantages of vaccination were most apparent in the barns with less than adequate sanitation and ventilation.
Bibliography:L
L73
ISSN:0003-1488
1943-569X